ylliX - Online Advertising Network
Press Release

Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can’t Catch Up

Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesday after the Indian government approved Bharat Biotech’s COVID-19 vaccine Covaxin, for children between the ages of 2 and 18. Ocugen is partnered with Bharat Biotech.

...read full article on Benzinga

ylliX - Online Advertising Network